Luke J Peppone
University of Rochester NCORP Research Base · University of Rochester
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Luke J Peppone as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:59 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05838716 · Vitamin D for Prostate Endocrine TherapyUniversity of Rochester · recruiting · Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 · principal investigator
- N/ANCT02064946 · High-dose Vitamin D Supplementation for ADT-induced Side EffectsUniversity of Rochester · completed · Prostatic Neoplasms, Bone Mineral Density Quantitative Trait Locus 3 · principal investigator
- Ph2NCT01419730 · Vitamin D and Physical Activity on Bone HealthUniversity of Rochester · active not recruiting · Bone Metabolism Biomarkers, Bone Mineral Density, Physical Fitness · principal investigator
- Ph2NCT01293682 · Effects of High Dose Calcitriol in Breast Cancer PatientsUniversity of Rochester · completed · Breast Cancer · principal investigator
- Ph2NCT00904033 · Calcitriol, Physical Activity, and Bone Health in Cancer SurvivorsUniversity of Rochester · completed · Breast Neoplasms, Bone and Bones · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2024 to 2026 · $345,232 awarded in 2026Same name and institution; not confirmed by an ID
- High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer PatientsR01CA258349 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2022 to 2026 · $638,258 awarded in 2026Grant number is on one of their registry trials
- Whole Food Plant-Based Lifestyle Adaptation for Nutrition Therapy in Patients with Metastatic Breast Cancer: The PLANT-MBC Study in NCORPU34CA304677 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2026 · $276,407 awarded in 2026Same name and institution; not confirmed by an ID
- Treatment of Refractory NauseaR01CA200579 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2017 to 2021 · $215,985 awarded in 2021Same name and institution; not confirmed by an ID
- Management of Cancer-Treatment-Induced Bone LossK07CA168911 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2013 to 2017 · $144,893 awarded in 2017Same name and institution; not confirmed by an ID
- Feasibility of Omega-3 Supplementation for Cancer-related FatigueR03CA175599 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2014 to 2015 · $76,750 awarded in 2015Same name and institution; not confirmed by an ID
- High-dose Vitamin D Supplementation for ADT-induced Side EffectsR21CA175793 · NCI · UNIVERSITY OF ROCHESTER · fiscal years 2014 to 2015 · $166,931 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN, Supriya G. Mohile · fiscal years 2014 to 2026Named on NCT05838716
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:59 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors.J Clin Oncol · 2013208 citationsRCR 7.0
- Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.Support Care Cancer · 2012117 citationsRCR 3.8
- Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors.Clin Breast Cancer · 2011104 citationsRCR 3.1
- Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan.J Cancer Surviv · 2012104 citationsRCR 3.5
- Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors.Integr Cancer Ther · 201970 citationsRCR 3.7
- YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and Sleep.Integr Cancer Ther · 201665 citationsRCR 2.8
- The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy.Breast Cancer Res Treat · 201562 citationsRCR 2.6
- Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors.J Geriatr Oncol · 201551 citationsRCR 2.0
- Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer Survivors.J Clin Sleep Med · 201951 citationsRCR 2.7
- Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial.Clin Breast Cancer · 201050 citationsRCR 1.5